Search

everythinglearnresearchcommunity

for

Search:↓

The effects of estrogen on human hair growth are unclear and need more research.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Minoxidil helps some bald men, but most lose hair again when stopping.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

The research found genetic differences in identical twins that could explain why one twin has a disease while the other does not.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

Feed restriction in sheep leads to finer wool fibers but may reduce wool quality.

Bimatoprost is safe and effective for improving eyebrow hair.

Vertex pattern hair loss linked to higher prostate cancer risk.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Low-level laser therapy effectively treats female hair loss, increasing hair count by 51%.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Suppressing certain hormones might help prevent prostate cancer.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.